SummaryAn abnormal circulating ganglioside was found in patients with neuroblastoma. This ganglioside appeared as a single band by resorcinol-HCl staining of thin-layer chromatograms of purified total gangliosides isolated from as little as 1 ml of patient plasma. It is a major ganglioside of neuroblastoma tumour tissue and was present (250-1500 pmol lipid-bound sialic acid/ml) in the plasma of five patients with widespread neuroblastoma. In contrast, the ganglioside was not detected (<50 pmol/ml) in plasma samples of six patients in complete remission, nor in plasma samples of seventeen healthy children and adults. Measurement of this circulating tumourassociated ganglioside should be clinically useful in neuroblastoma, offering a new approach to the detection of tumour and the evaluation of therapy.

The incidence of deficiency of the enzyme pyruvate kinase (PK) in Chinese infants was determined. Both the standard assay of erythrocyte pyruvate kinase enzyme activity and a fluorescent screening test (standardized) were used. The results of these two tests were compared. Of 1,159 infant cord blood samples studied, 26 (or 2.2%) had abnormally low levels of PK activity using the screening test, as did 24 of the samples tested by the enzyme assay. The results indicate that the frequency of a defective PK gene in the population of Guangzhou is significantly lower (p less than .05) than the previously reported defective gene frequency of 3.4% in Hong Kong. They also demonstrate the critical importance of standardization of the screening test, if most accurate estimates of gene frequency are to be derived by using this test.